BRAINSTORM CELL THERAPUTC
BCLI
BCLI was delisted on the 17th of July, 2025.
11 hedge funds and large institutions have $488K invested in BRAINSTORM CELL THERAPUTC in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
57% more funds holding
Funds holding: 7 → 11 (+4)
7% more capital invested
Capital invested by funds: $457K → $488K (+$30.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
+$129K |
| 2 |
M&T Bank
Buffalo,
New York
|
+$81.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.4K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$40.9K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$35.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$265K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$178K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIM
1
Spark Investment Management
New York
| $175K | +$129K | +2,453 | New |
|
|
2
M&T Bank
Buffalo,
New York
| $111K | +$81.7K | +1,556 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $82K | +$60.4K | +1,149 | New |
|
|
VKH
4
Virtu KCG Holdings
New York
| $56K | +$40.9K | +779 | New |
|
|
5
HighTower Advisors
Chicago,
Illinois
| $49K | +$35.9K | +684 | New |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | +$1.73K | +33 | +92% |
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $3K | +$2.31K | +44 | New |
|
10
US Bancorp
Minneapolis,
Minnesota
| $1K | +$946 | +18 | New |
|
|
SM
11
Sabby Management
Miami Beach,
Florida
| – | -$3.32K | -53,884 | Closed |
|
|
SFM
12
Sphera Funds Management
Tel Aviv,
Israel
| – | -$265K | -4,222 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$178K | -2,889 | Closed |
|
|
BCM
14
Blume Capital Management
Berkeley,
California
| – | +$210 | +4 | New |
|
BCLI Hedge Fund Activity: Q4 2014 in Review
11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q4 2014, worth a combined $488K — up 6.7% from $457K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BCLI positions and 3 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Spark Investment Management, opening a new position worth an estimated $129K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $265K sold.
- 11 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q4 2014, up from 7 in Q3 2014.
- Funds reported $488K of BRAINSTORM CELL THERAPUTC stock for Q4 2014, up 6.7% quarter-over-quarter.
- 8 funds opened new BRAINSTORM CELL THERAPUTC positions in Q4 2014 and 3 closed out, a net change of +5 holders.
- The largest BRAINSTORM CELL THERAPUTC buyer in Q4 2014 was Spark Investment Management, an estimated $129K added.
- The largest BRAINSTORM CELL THERAPUTC seller in Q4 2014 was Sphera Funds Management, an estimated $265K sold.
Based on aggregated 13F filings for Q4 2014.